2026 NPPES data Addiction Medicine (Psychiatry & Neurology) Physician NPI 1538665229
Verify on CMS →

MEGAN SCHWARTZ

Addiction Medicine (Psychiatry & Neurology) Physician in MAGNA, Utah. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 203 beneficiaries · Addiction Medicine (Psychiatry & Neurology) Physician avg: 1K
Generic prescribing
90%
generic claims · 10% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
93.3313/100
▲ 10 pts above national avg 83.1 · [object Object]
Industry payments
$1.6K
79 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MEGAN SCHWARTZ reported a CMS MIPS final score of 93.3313/100 — above the 83.1 national average — and filed 2,250 Medicare Part D claims in 2023.

93.3313/100
MIPS score · +10 vs avg
2K
Part D claims, 2023
90%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MEGAN SCHWARTZ's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

93 Top 29% higher than 71% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

MEGAN SCHWARTZ practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MEGAN SCHWARTZ?

High performer (top quartile)

NPI registry status

Active

Issued 04/02/2018

NPI 1538665229

Primary specialty

Addiction Medicine (Psychiatry & Neurology) Physician

Niche

658 US NPIs in this specialty

Medicare Part D claims

2,250 121% vs specialty avg

2023 prescription claims

Specialty avg: 1,019

MIPS final score

93.3313/100 10.231300000000005% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Utah

How Addiction Medicine (Psychiatry & Neurology) Physician compares to other specialties among Utah providers

Utah providers

Addiction Medicine (Psychiatry & Neurology) Physician share within Utah

1. Addiction Medicine (Psychiatry & Neurology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Addiction Medicine (Psychiatry & Neurology) Physician share within Utah

Medicare quality performance — MIPS

MEGAN SCHWARTZ's 2023 MIPS final score plotted against the Addiction Medicine (Psychiatry & Neurology) Physician national average

High performer (top quartile)
MIPS Final Score
93.3313/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Addiction Medicine (Psychiatry & Neurology) Physician) — 93.3313/100 vs national avg 83.1

0%100%National avg83%93.3%
MIPS final score (Addiction Medicine (Psychiatry & Neurology) Physician) — 93.3313/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MEGAN SCHWARTZ appears in the CMS NPPES registry as a Addiction Medicine (Psychiatry & Neurology) Physician provider at 3665 S 8400 W, MAGNA, UT, 84044, with a listed phone of (801) 250-9638. NPI 1538665229 was issued on 04/02/2018. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SCHWARTZ most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 2,250 prescription claims written by this provider, covering 203 Medicare beneficiaries and totaling roughly $168K in drug spend, split 10% brand-name and 90% generic by claim count, with an opioid prescribing rate of 1.8%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 93.3313/100 for the 2023 performance year (Quality 86.6626), compared with the national average of 83.1.

Addiction Medicine (Psychiatry & Neurology) Physician is a narrow specialty nationwide, with 658 enrolled providers across 49 states and an average of 1,019 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

3665 S 8400 W
MAGNA, UT 84044

Provider Details

NPI 1538665229
Specialty Addiction Medicine (Psychiatry & Neurology) Physician
Gender Female
NPI Issued 04/02/2018

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

93.3313
Final Score
Avg: 83.1
86.6626
Quality
100
Promoting Interoperability

Reporting: Alternative Payment Model

Hospital and facility affiliations

Facilities where MEGAN SCHWARTZ bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

OLYMPUS CLINIC
SALT LAKE CITY, UT

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MEGAN SCHWARTZ. Source: openpaymentsdata.cms.gov.

Total received

$1.6K

Largest payer

ABBVIE INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

MEGAN SCHWARTZ — brand share 10.0%
Specialty average (est.)

10% brand-name claims vs 90% generic, on 2,250 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,250
Total Claims
$168K
Total Drug Cost
203
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
4,382
Total Day Supply
127,530
Brand vs Generic
10% brand / 90% generic
Brand Drug Cost
$121K
Generic Drug Cost
$46K
Opioid Claims
40 (1.8% rate)
Antibiotic Claims
25

Patient Demographics

Average Patient Age
67.6 years
Avg HCC Risk Score
1.44
Gender Split
65% female / 35% male
Age Distribution
<65: 63, 65-74: 95, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MEGAN SCHWARTZ prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Atorvastatin Calcium
133
Lisinopril
109
Levothyroxine Sodium
92
Gabapentin
90
Losartan Potassium
79
Omeprazole
78
Amlodipine Besylate
63
Duloxetine Hcl
60
Simvastatin
49
Albuterol Sulfate Hfa
Albuterol Sulfate
48

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Addiction Medicine (Psychiatry & Neurology) Physician Overview

How MEGAN SCHWARTZ fits within the Addiction Medicine (Psychiatry & Neurology) Physician landscape nationally.

658
Addiction Medicine (Psychiatry & Neurology) Physician Providers in US
49
States with Addiction Medicine (Psychiatry & Neurology) Physician
1,019
Avg Claims per Provider

MEGAN SCHWARTZ's 2,250 claims are above the specialty average of 1,019.

Nearby Addiction Medicine (Psychiatry & Neurology) Physician Providers in Utah

Other clinicians with the same primary specialty enrolled in Utah, drawn from the same CMS NPPES roster as SCHWARTZ.

Compare Addiction Medicine (Psychiatry & Neurology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MEGAN SCHWARTZ's specialty?
MEGAN SCHWARTZ specializes in Addiction Medicine (Psychiatry & Neurology) Physician and practices in MAGNA, Utah.
How much does MEGAN SCHWARTZ prescribe under Medicare Part D?
In 2023, MEGAN SCHWARTZ wrote 2,250 Medicare Part D claims totaling $168K in drug costs for 203 beneficiaries.
What is MEGAN SCHWARTZ's Medicare quality score?
MEGAN SCHWARTZ has a CMS MIPS Final Score of 93.3313/100 (Quality: 86.6626). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MEGAN SCHWARTZ located?
MEGAN SCHWARTZ is located at 3665 S 8400 W, MAGNA, UT, 84044. Phone: (801) 250-9638.
What is MEGAN SCHWARTZ's NPI number?
MEGAN SCHWARTZ's National Provider Identifier (NPI) is 1538665229, issued on 04/02/2018.
Does MEGAN SCHWARTZ prescribe more brand-name or generic drugs?
MEGAN SCHWARTZ's prescribing is 10% brand-name and 90% generic drugs by claim count, with $121K in brand drug costs.
Does MEGAN SCHWARTZ prescribe opioids?
Yes, MEGAN SCHWARTZ had 40 opioid claims in 2023 with an opioid prescribing rate of 1.8%.
How many Addiction Medicine (Psychiatry & Neurology) Physician providers are there in the US?
There are 658 Addiction Medicine (Psychiatry & Neurology) Physician providers across 49 states in the US. The average Addiction Medicine (Psychiatry & Neurology) Physician provider writes 1,019 Medicare Part D claims per year.
What drugs does MEGAN SCHWARTZ prescribe most often?
Based on 2023 Medicare Part D data, MEGAN SCHWARTZ's most frequently prescribed drugs include Atorvastatin Calcium, Lisinopril, Levothyroxine Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MEGAN SCHWARTZ accept Medicare?
MEGAN SCHWARTZ appears in CMS Medicare data with 2,250 Part D claims and 203 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MEGAN SCHWARTZ's credentials?
MEGAN SCHWARTZ's NPI is 1538665229. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology